Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein

The multidrug resistance-associated protein (MRP) mediates the cellular excretion of many drugs, glutathione S-conjugates (GS-X) of lipophilic xenobiotics and endogenous cysteinyl leukotrienes1–5. Increased MRP levels in tumor cells can cause multidrug resistance (MDR) by decreasing the intracellular drug concentration. The physiological role or roles of MRP remain ill-defined, however. We have generated MRP-deficient mice by using embryonic stem cell technology. Mice homozygous for the mrp mutant allele, mrp−/−, are viable and fertile, but their response to an inflammatory stimulus is impaired. We attribute this defect to a decreased secretion of leukotriene C4 (LTC4) from leukotriene-synthesizing cells. Moreover, the mrp−/− mice are hypersensitive to the anticancer drug etoposide. The phenbtype of mrp−/− mice is consistent with a role for MRP as the main LTC4-exporter in leukotriene-synthesizing cells, and as an important drug exporter in drug-sensitive cells. Our results suggest that this ubiquitous6 GS-X pump7,8 is dispensable in mice, making treatment of MDR with MRP-specific reversal agents potentially feasible.

[1]  I. Pastan,et al.  Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.

[2]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[3]  P. Borst,et al.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Saxena,et al.  MOAT4, a novel multispecific organic-anion transporter for glucuronides and mercapturates in mouse L1210 cells and human erythrocytes. , 1996, The Biochemical journal.

[5]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[7]  F. Baas,et al.  Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Borst,et al.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Cole,et al.  Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. , 1996, Molecular pharmacology.

[10]  R. Viëtor,et al.  Rapid, simple and efficient extraction of arachidonic acid metabolites, including the sulphidopeptide leukotrienes LTC4 and LTD4, using octadecyl reversed-phase extraction columns. , 1986, Journal of chromatography.

[11]  E. Opas,et al.  Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. , 1985, The Journal of investigative dermatology.

[12]  C. Funk,et al.  Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene , 1994, Nature.

[13]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[14]  S. Cole,et al.  Biology of the multidrug resistance-associated protein, MRP. , 1996, European journal of cancer.

[15]  M. Flens,et al.  Tissue distribution of the multidrug resistance protein. , 1996, The American journal of pathology.

[16]  E. Corey,et al.  Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Keppler,et al.  The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.

[18]  R. Evers,et al.  Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP , 1996, FEBS letters.

[19]  B. Koller,et al.  Altered inflammatory responses in leukotriene-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Bosma,et al.  Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.

[21]  K. Austen,et al.  Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Ishikawa,et al.  The ATP-dependent glutathione S-conjugate export pump. , 1992, Trends in biochemical sciences.

[23]  D. Keppler,et al.  Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. , 1996, Cancer research.

[24]  B. Undem,et al.  Cysteinyl leukotrienes in asthma: old mediators up to new tricks. , 1995, Trends in pharmacological sciences.

[25]  D. Keppler,et al.  Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. , 1996, European journal of biochemistry.

[26]  T. Ishikawa,et al.  Coordinated Induction of MRP/GS-X Pump and γ-Glutamylcysteine Synthetase by Heavy Metals in Human Leukemia Cells* , 1996, The Journal of Biological Chemistry.

[27]  P. Laird,et al.  Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells. , 1993, Blood.

[28]  R. Flavell,et al.  Double knockout of the MRP gene leads to increased drug sensitivity in vitro. , 1996, Cancer research.